Reply to: “Letter to the Editor: Association Between Frailty and Short‐Term Treatment‐Related Adverse Events in Patients With Overactive Bladder”

Documenti analoghi

• Impact of Lower Urinary Tract Symptoms on Daily Life in Individuals With Co‐Existence Overactive and Underactive Bladder, Overactive Bladder, and Underactive Bladder
  di: Noritoshi Sekido, et al.
  Pubblicazione: (2025)
• Overactive Bladder is Positively Associated With the Prevalence and Mortality of Cancer Among US Adults
  di: Jianing Liu, et al.
  Pubblicazione: (2025)
• Selective Bladder Denervation via Radiofrequency Ablation Versus Intravesical Onabotulinum Toxin A for Refractory Overactive Bladder: The Short‐Term Results of A Preliminary Randomized Controlled Trial
  di: Salih Zeki Sönmez, et al.
  Pubblicazione: (2025)
• Safety and Effectiveness of Vibegron in Japanese Patients With Overactive Bladder: A Japanese Postmarketing Survey
  di: Shoko Yoshimura, et al.
  Pubblicazione: (2024)
• Systemic Immune‐Inflammation Index and Neutrophil‐To‐Lymphocyte Ratio: U‐Shaped Association With Overactive Bladder
  di: Qinglong Yang, et al.
  Pubblicazione: (2025)